Neoplasms

3,817 trials 1,526 recruiting

Filter these 3,817 trials by phase, country and sponsor.

Open in Search →

A Randomized, Open-label Phase 3 Study of Combination Amivantamab and CarboplatinPemetrexed Therapy, Compared with Carboplatin-Pemetrexed, i… Ended

2023-506033-29-00 EGFR Exon 20ins Mutated Locally Advanced or Metastatic 5 2020-10-09
A Clinical Trial to evaluate the Efficacy and Safety of of Oral Paclitaxel (DHP107) Compared to IV Paclitaxel as First-line Therapy in Patie… Ended

2024-517090-24-00 Recurrent or Metastatic HER2 Negative Breast Cancer 10 2020-10-09
A Phase 1, Open-Label, Study Evaluating the Safety, Pharmacokinetics, and Clinical Effects of Intravenously Administered PT-112 Injection in… Ended

2024-518506-41-00 metastatic castrate resistant prostate cancer 9 2020-10-05
Evaluation of a treatment with bendamustine, followed by obinutuzumab, zanubrutinib and venetoclax in patients with relapsed chronic lymphoc… Ended

2022-502201-16-00 Relapsed/refractory chronic lymphocytic leukemia 4 2020-09-30
A Clinical Study of Amivantamab and Lazertinib Combination Therapy Versus Osimertinib Versus Lazertinib as First-Line Treatment in Patients … Ended

2023-506576-27-00 EGFR-mutated locally advanced or metastatic Non Small C 5 2020-09-30
A study comparing the efficacy and safety of osimertinib when given in combination with chemotherapy versus osimertinib alone in patients wi… Ended

2023-508800-39-00 Patients with locally-advanced or metastatic EGFRm (Ex1 5 2020-09-29
A Clinical trial to compare the combination of Isatuximab-Carfilzomib-Lenalidomide-Dexamethasone versus the combination of Carfilzomib-Lenal… Ended

2024-513422-38-00 Newly diagnosed multiple myeloma 5 2020-09-28
A study of a combination of Belantamab Mafodotin with Pomalidomide and Dexamethasone (B-Pd) compared to Bortezomib with Pomalidomide and Dex… Ended

2023-506877-37-00 Relapsed/Refractory Multiple Myeloma 5 2020-09-28
Study of Cabozantinib in Combination With Atezolizumab compared to Second Novel Hormonal Therapy (NHT) in Subjects with Metastatic Castratio… Ended

2024-516481-11-00 Metastatic Castration-Resistant Prostate Cancer 5 2020-09-22
A Phase 1, Open-label, Multicenter, Dose-escalation Study of CK-301 Administered Intravenously as a Single Agent to Subjects with Advanced C… Ended

2024-517536-22-00 Unresectable or metastatic cutaneous squamous cell carc 7 2020-09-22
An Open-label, Phase 1b/2 Study of Acalabrutinib Alone or in Combination Therapy in Subjects with B-cell Non-Hodgkin Lymphoma Ended

2023-509350-63-00 Relapsed/Refractory marginal zone lymphoma 9 2020-09-16
EMBER: A Study of LY3484356 in Patients with Breast or Other Non-Breast Cancers Ended

2023-506785-32-00 Breast Cancer 3 2020-09-11
Hepatic arterial infusion PUMP chemotherapy combined with systemIc chemoTherapy for potentially resectable colorectal liver metastases. - Th… Ended

2024-515525-28-00 colorectal adenocarcinoma 10 2020-09-10
A Clinical Study to Evaluate the Safety and Pharmacokinetics of JNJ- 73841937 (Lazertinib), a Third Generation EGFR-TKI, as Monotherapy or i… Ended

2023-506577-35-00 Advanced Non-Small Cell Lung Cancer 3 2020-09-08
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial Ended

2022-501522-38-00 Chronic lymphocytic leukemia; Non-Hodgkin's lymphoma; M 5 2020-09-04
A Study Evaluating the Efficacy and Safety of Inavolisib Plus Palbociclib and Fulvestrant versus Placebo Plus Palbociclib and Fulvestrant in… Ended

2023-505812-39-00 HR+/HER2-Negative Locally Advanced or Metastatic Breast 5 2020-08-28
An open-label clinical trial evaluating enfortumab vedotin in combination with pembrolizumab versus chemotherapy alone in previously untreat… Ended

2023-503421-19-00 Urothelial cancer 5 2020-08-26
Clinical trial to compare efficacy and safety of standard chemotherapy versus letrozole plus abemaciclib, chosen randomly, as neoadjuvant th… Ended

2024-514395-40-00 High/intermediate risk hormone receptor (HR) positive/h 4 2020-08-25
A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed … Ended

2022-502746-27-00 Endometrial Cancer 5 2020-08-21
Reduced intensity radio-chemotherapy for stage IIA/B seminoma Ended

2023-509663-24-00 Stage IIA/B seminoma 4 2020-08-20
POLAR BEAR Ended

2022-502887-19-00 Diffuse Large B-Cell Lymphoma 5 2020-08-18
Study of Rapcabtagene autoleucel (YTB323) in adult patients with CLL/SLL, 3L+ DLBCL, r/r ALL and 1L HR LBCL Ended

2023-507062-34-00 High-Risk large B-Cell lymphoma 7 2020-08-07
Study with apalutamide in patients with prostate cancer in whom the prostate has been removed who are at high risk of disease recurrence Ended

2024-511832-29-00 High risk adenocarcinoma of the prostate after radical 4 2020-08-05
Investigation of Radium-223 dichloride (Xofigo), a treatment that gives off radiation that helps kill cancer cells, compared to a treatment … Ended

2023-505830-89-00 metastatic castrate resistant prostate cancer (mCRPC) 6 2020-08-05